ORPH NASDAQ
Orphazyme A/S
1W: -2.5%
1M: -29.3%
3M: -65.3%
1Y: -89.6%
$0.87
Last traded 2022-03-30 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
-100.0% YoY
$-61M
Net Income
+94.4% YoY
$-104M
Free Cash Flow
+89.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-129.0%
ROA-109.1%
ROIC662.9%
Valuation
P/E-7.8
P/B14.2
EV/EBITDA0.0
Leverage
Debt/Equity0.00
Current Ratio10.14
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z—
Beneish M0.00